U.S. jury clears Eli Lilly in first Cymbalta withdrawal trial

(Reuters) – Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and electric shock-like sensations, the company said. Eli Lily has been sued by roughly 250 plaintiffs who say that the company downplayed warnings about symptoms that can occur when patients quit the popular drug, which has annual sales of about $3.9 billion. The trial this week on the lawsuit filed by Claudia Herrera in federal court in California is the first of four trials over Cymbalta withdrawal scheduled for this month. “While Lilly is sympathetic to Ms. Herrera’s conditions, we are pleased with the jury’s verdict,” Lilly spokeswoman Celeste Stanley said.
Go to Source